Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden (Q98578690)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

title

Antibiotic use and the development of inflammatory bowel disease: a national case-control study in Sweden (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

1 reference

inflammatory bowel diseases

1 reference

Long H Nguyen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Anne K Örtqvist

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Yin Cao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Tracey G Simon

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Bjorn Roelstraete

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Mingyang Song

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Amit D Joshi

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Kyle Staller

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Andrew T Chan

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Hamed Khalili

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Ola Olén

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

Jonas F Ludvigsson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

publication date

17 August 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

The lancet. Gastroenterology & hepatology

23 August 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

Epidemiology and risk factors for IBD.

23 August 2020

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Inflammatory Bowel Disease Environmental Risk Factors: A Population-Based Case-Control Study of Middle Eastern Migration to Australia

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Global increase and geographic convergence in antibiotic consumption between 2000 and 2015.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Multi-omics of the gut microbial ecosystem in inflammatory bowel diseases

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotic use and the development of Crohn's disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotic Use and New-Onset Inflammatory Bowel Disease in Olmsted County, Minnesota: A Population-Based Case-Control Study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Association between the use of antibiotics and new diagnoses of Crohn's disease and ulcerative colitis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Population-based cases control study of inflammatory bowel disease risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Potential association between the oral tetracycline class of antimicrobials used to treat acne and inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Risk factors for inflammatory bowel diseases according to the "hygiene hypothesis": a case-control, multi-centre, prospective study in Southern Italy

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Environmental factors in the development of chronic inflammation: a case-control study on risk factors for Crohn's disease within New Zealand.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Association between the use of antibiotics in the first year of life and pediatric inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Association of repeated exposure to antibiotics with the development of pediatric Crohn's disease--a nationwide, register-based finnish case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Fetal and early life antibiotics exposure and very early onset inflammatory bowel disease: a population-based study.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotic exposure and IBD development among children: a population-based cohort study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotic use and inflammatory bowel diseases in childhood

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Systematic evaluation of risk factors for diagnostic delay in inflammatory bowel disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Child Health Systems in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

External review and validation of the Swedish national inpatient register

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Cohort profile: ESPRESSO (Epidemiology Strengthened by histoPathology Reports in Sweden)

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Oral antibiotic use and risk of colorectal cancer in the United Kingdom, 1989-2012: a matched case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

The longitudinal integrated database for health insurance and labour market studies (LISA) and its use in medical research

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Dietary Intake and Risk of Developing Inflammatory Bowel Disease: A Systematic Review of the Literature

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Understanding and Preventing the Global Increase of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Inflammatory bowel disease in a Swedish twin cohort: a long-term follow-up of concordance and clinical characteristics.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Incomplete recovery and individualized responses of the human distal gut microbiota to repeated antibiotic perturbation

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Recovery of gut microbiota of healthy adults following antibiotic exposure

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

The effects of antibiotics on the microbiome throughout development and alternative approaches for therapeutic modulation

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotic use and microbiome function

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

A Dietary Fiber-Deprived Gut Microbiota Degrades the Colonic Mucus Barrier and Enhances Pathogen Susceptibility

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotics promote inflammation through the translocation of native commensal colonic bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Association Between Circulating Levels of C-Reactive Protein and Interleukin-6 and Risk of Inflammatory Bowel Disease

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Serological markers predict inflammatory bowel disease years before the diagnosis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Links of Autophagy Dysfunction to Inflammatory Bowel Disease Onset

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Microbiota-activated PPAR-γ signaling inhibits dysbiotic Enterobacteriaceae expansion

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Commensal microbes provide first line defense against Listeria monocytogenes infection.

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Depletion of Butyrate-Producing Clostridia from the Gut Microbiota Drives an Aerobic Luminal Expansion of Salmonella

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotics associated with increased risk of new-onset Crohn's disease but not ulcerative colitis: a meta-analysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Antibiotic exposure and the development of coeliac disease: a nationwide case-control study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

The new Swedish Prescribed Drug Register--opportunities for pharmacoepidemiological research and experience from the first six months

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Nationwide prevalence of inflammatory bowel disease in Sweden: a population-based register study

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Incidence and Treatment of Patients Diagnosed With Inflammatory Bowel Diseases at 60 Years or Older in Sweden

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Indeterminate colitis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

Frequency of indeterminate colitis in children and adults with IBD - a metaanalysis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2820%2930267-3

7 January 2021

10.1016/S2468-1253(20)30267-3

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:32818437%20AND%20SRC:MED&resulttype=core&format=json

23 August 2020

1 reference